medline.ch Onkologie Respirationstrakt

	Serum NLRP3 levels are associated with postoperative delirium of elderly patients with lung cancer: an observational analytical study. Front Neurol Cheng Y, Liu Y, Tan G, Huang M, Wu X, Chen X. PMID: 42871060 [PubMed - indexed for MEDLINE]
	Regional disparities in lung cancer surgery and survival in South Korea: a nationwide population-based retrospective cohort study using linked cancer registry and national health insurance data. Transl Lung Cancer Res Kim HS, Yeob KE, Kim SY, Han HS, Park JH. PMID: 42870884 [PubMed]
	Prognostic impact of immune-related adverse events in non-completers of durvalumab consolidation therapy for non-small cell lung cancer: a single-center retrospective cohort study. Transl Lung Cancer Res Ebi N, Kawabata R, Fujimoto M, Hirata A, Sakaki Y, Otsuka Y, Kinoshita E, Shundo Y, Yanagihara T, Inoue H, Fujita M. PMID: 42870864 [PubMed]
	Vietnamese expert consensus on the diagnosis and multidisciplinary management of resectable non-small cell lung cancer. Transl Lung Cancer Res Do QK, Pham DX, Nguyen HTT, Binh NH, Nguyen KT, Lam TQ, Truong TT, Trinh DT, Le DT, Le AT, Le HT, Nguyen DTN. PMID: 42870861 [PubMed]
	Efficacy and safety of osimertinib combined with anlotinib in EGFR-mutant non-squamous non-small cell lung cancer with gradual progression after first-line osimertinib therapy: a single-center retrospective cohort study. Transl Lung Cancer Res Hao L, Yu H, Wang Y, Pan Y, Han X. PMID: 42870856 [PubMed]
	Plasma proteomic profiles associated with low-dose computed tomography findings and incident lung cancer: a prospective pilot study. Transl Lung Cancer Res Tikkanen A, Iivanainen S, Luukkainen MEK, Koivunen JP. PMID: 42870850 [PubMed]
	Efficacy and safety of third-generation EGFR-TKI rechallenge therapy in advanced non-small cell lung cancer patients with EGFR mutation: a retrospective cohort study. Transl Lung Cancer Res Sun J, Li X, Wang B, Chen Z, Yao Y, Wu R, Pan X, Xu X, Si Y, Liu H. PMID: 42870834 [PubMed]
	Efficacy and safety of antibody-drug conjugates in advanced small cell lung cancer: a systematic review and single-arm meta-analysis of prospective clinical trials. Transl Cancer Res Zhang P, Zhao W, Ma J, Li Y, Peng H, Jiang J. PMID: 42870825 [PubMed]
	Exploratory study to evaluate the combined effect of CBM588: Clostridium butyricum in platinum plus pemetrexed with pembrolizumab for non-small cell lung cancer-protocol of MIYABRO study. Transl Lung Cancer Res Tagawa R, Taniguchi H, Kaku N, Akagi K, Tomono H, Honda N, Dotsu Y, Matsuo M, Takemoto S, Itagaki A, Yamashita K, Umeyama Y, Gyotoku H, Ikeda T, Sugasaki N, Yoshiyama K, Kitazaki T, Nakatomi K, Takao D, Fukuda M, Yanagihara K, Mukae H. PMID: 42870820 [PubMed]
	Amivantamab plus chemotherapy vs. chemotherapy in participants with EGFR-mutant advanced non-small cell lung cancer after progression on osimertinib: a MARIPOSA-2 analysis of the Asian subgroup. Transl Lung Cancer Res Shih JY, Wang J, Wang Y, Wang J, Lee SH, Azuma K, Takahashi T, Tan JL, Lin CC, Ganguly S, Lee VH, Turna ZH, Sharma R, Kim YJ, Chu PL, Shah S, Diorio B, Cho BC. PMID: 42870814 [PubMed]
	Adjuvant alectinib versus crizotinib in completely resected ALK-positive non-small-cell lung cancer: a real-world retrospective cohort study. Transl Lung Cancer Res Yang Y, Liang S, Liu R, Tian J, Luo X, Ma G. PMID: 42870811 [PubMed]
	Deferring or delivering stereotactic radiosurgery in EGFR-mutated non-small cell lung cancer: lessons from the STARLET randomized analysis. Transl Lung Cancer Res Sheehan JP, Chung JH, Mantziaris G, Penberthy DR, Fadul CE. PMID: 42870805 [PubMed]
	Clinical Value of SHOX2 and RASSF1A Methylation Combination in BALF Samples for the Diagnosis of Lung Cancer. J Environ Pathol Toxicol Oncol Zeng S, He X, Tan Y, He Z, Huang Y. PMID: 42870609 [PubMed - indexed for MEDLINE]
	Considerations regarding a meta-analysis investigating the efficacy and safety of robotic-assisted thoracic surgery after neoadjuvant therapy in non-small cell lung cancer. Updates Surg Jiao B, Wang L. PMID: 42870217 [PubMed - as supplied by publisher]
	Using Digital Outreach to Identify Individuals Eligible for Lung Cancer Screening: A Secondary Analysis of a Randomized Trial. J Gen Intern Med Bundy R, Snavely AC, Miller DP, Reuland DS, Ferrari RM, Bellinger C, Randazzo A, Stradtman L, Wright E, Brenner AT, Dharod A. PMID: 42870174 [PubMed - as supplied by publisher]
	Camrelizumab plus chemotherapy as induction therapy followed by concurrent chemoradiotherapy and camrelizumab consolidation in limited-stage small cell lung cancer: a randomized phase II trial. Signal Transduct Target Ther Liu D, Yang L, Hu M, Du H, Chen Y, Zhu Y, Kang J, Yuan X, Yang S, Xu Q, Ren S, Ni J, Zhou C, Xu Y. PMID: 42869886 [PubMed - indexed for MEDLINE]
	Pulmonary nodules: classification, biomarkers, signaling pathways, diseases, early diagnosis and management. Signal Transduct Target Ther Ye Z, Li L, Zhang M, Su W, Li X, Anwaar S, Xiang M, Yin Y, Liu M, Yin M. PMID: 42869881 [PubMed - indexed for MEDLINE]
	Emerging landscape of antibody-drug conjugates in lung cancer: a clinical review. Trends Cancer Pickett H, Arias-Romero J, Fricke J, Mambetsariev I, Chen N, Bruno DS, Lee M, Amini A, Malhotra J, Salgia R. PMID: 42869767 [PubMed - as supplied by publisher]
	American Radium Society Appropriate Use Criteria: Accelerated hypofractionated radiotherapy in the multidisciplinary management of locally-advanced non-small cell lung cancer ineligible for concurrent chemotherapy. Int J Radiat Oncol Biol Phys Chun SG, Iyengar P, Rimner A, Amini A, Donington J, Edelman MJ, Feigenberg SJ, Geng Y, Gubens MA, Higgins KA, Juloori A, Ning MS, Park HS, Slotman BJ, Wolf AS, Simone CB 2nd. PMID: 42869299 [PubMed - as supplied by publisher]
	Adenoma laterality and risk of subsequent colorectal cancer: Secondary analysis of the Prostate, Lung, Colorectal, and Ovarian Cancer trial. Surgery Frebault J, Troester A, Huo L, Rudser K, Hassan I, Shaukat A, Goffredo P. PMID: 42868921 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 162718

Seite 1 von 8136

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung